OTC Markets OTCPK - Delayed Quote USD
Daiichi Sankyo Company, Limited (DSKYF)
26.00
-0.05
(-0.19%)
At close: May 2 at 3:47:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in JPY | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 13 | 14 |
| Avg. Estimate | 456.2B | 503.9B | 2.1T | 2.39T |
| Low Estimate | 448.4B | 486.8B | 2T | 2.06T |
| High Estimate | 464B | 521B | 2.28T | 2.78T |
| Year Ago Sales | 436.18B | 446.52B | 1.36T | 2.1T |
| Sales Growth (year/est) | 4.59% | 12.85% | 54.56% | 13.80% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DSKYF | -- | -- | -- | -- |
| S&P 500 | 12.40% | 3.81% | 8.28% | 13.79% |
Related Tickers
4AB.BE AbbVie Inc
175.40
+2.45%
MRK.NE Merck & Co., Inc.
19.13
+0.10%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.59
+1.18%
RHHBF Roche Holding AG
345.35
+16.67%
GLAXF GSK plc
18.95
0.00%
AZNCF AstraZeneca PLC
146.74
0.00%
PFE.NE Pfizer Inc.
11.12
+0.91%
LLY.NE Eli Lilly and Company
30.45
+3.85%
BAYRY Bayer Aktiengesellschaft
6.74
-0.15%
NONOF Novo Nordisk A/S
68.40
-2.15%